CMS
Tempus Nabs CMS Advanced Diagnostic Laboratory Test Status for Tumor Mutation Profiling Test
The xT CDx is a next-generation sequencing-based assay that is used for the detection of substitutions, insertions, and deletions and microsatellite instability status.
Sickle Cell Gene Therapy Fertility Risks Spur Calls for Changes Allowing Industry Support Services
Gene therapy companies aren't covering fertility preservation for Medicaid patients due to anti-kickback laws, but CMS is exploring solutions in a model.
With Seagen integrated into its business, Pfizer has new sources of revenue and forthcoming data readouts on precision oncology drugs.
The drugmaker will seek regulatory approval for Scemblix in first-line Ph-positive CML and other precision drugs in the coming months.
BioCardia Nabs Medicare Coverage for Heart Failure Cell Therapy Phase III Trial
The decision by CMS will allow Medicare-eligible patients in the study to receive coverage for CardiAMP treatment and related services.
Nov 30, 2023
Sep 21, 2023